Brief: Wanbury Says Patalganga Site Has Completed Korea FDA Regulatory Inspection Successfully
28/04/2026 14:13
April 28 (Reuters) - Wanbury Ltd WANB.NS: WANBURY LTD - PATALGANGA SITE HAS COMPLETED KOREA FDA REGULATORY INSPECTION SUCCESSFULLY Source text: ID:nBSEcbw68G Further company coverage: WANB.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Wanbury
See all newsBrief: Wanbury Says Tanuku API Site Completes TGA Quality Inspection
Brief: Wanbury Expanded Regulatory Submission For New Active Pharmaceutical Ingredients
Brief: Wanbury Says Patalganga Site Has Completed Korea FDA Regulatory Inspection Successfully
Brief: Wanbury Ltd Launches Coriminic CPM Drops For Pediatric Use
Brief: Wanbury Receives Sertraline Form II Approval From Anvisa, Brazil